Express delivery and free returns within 21 days

Monday, June 27, 2022



Contact us 561.316.3330


Spinal Cord Stimulation

Stimwave and Nevro Reach Settlement In Patent Infringement Lawsuit

As part of the settlement, Stimwave has agreed to cease commercialization of all high frequency spinal cord stimulation systems, globally, in exchange for dismissal of the lawsuit with no damages assessed. The settlement pertains exclusively to spinal cord stimulation (SCS) and does not affect in any way Stimwave’s commercialization of its peripheral nerve stimulation (PNS) products for chronic pain management.

By using this website you agree to accept Medical Device News Magazine Privacy Policy